ZyVersa Therapeutics Inc.
1.38
-0.11 (-7.38%)
At close: Jan 15, 2025, 10:20 AM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 3.14M 5.90M 328.58K 174.67K
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a
Other Long-Term Assets 98.48K 46.66K 286.66K 308.32K
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 215.46K 460.35K 483.20K 164.44K
Total Current Assets 3.35M 6.36M 811.78K 339.11K
Property-Plant & Equipment 14.77K 115.70K 27.73K 38.13K
Goodwill & Intangibles 18.65M 111.98M n/a n/a
Total Long-Term Assets 18.76M 112.14M 314.39K 346.46K
Total Assets 22.11M 118.51M 1.13M 685.57K
Account Payables 8.43M 6.03M 2.00M 2.31M
Deferred Revenue n/a n/a 765.68K 1.18M
Short-Term Debt 8.66K 108.76K 9.15M 2.13M
Other Current Liabilities 1.75M 1.95M 2.46M 3.09M
Total Current Liabilities 10.19M 8.19M 13.63M 7.56M
Long-Term Debt n/a n/a n/a 1.69M
Other Long-Term Liabilities n/a n/a n/a n/a
Total Long-Term Liabilities 844.91K 10.32M n/a 1.69M
Total Liabilities 11.04M 18.51M 13.63M 9.24M
Total Debt 8.66K 108.76K 9.15M 3.82M
Common Stock 405.00 902.00 242.00 242.00
Retained Earnings -103.22M -4.92M -52.90M -44.81M
Comprehensive Income n/a n/a -331.33K -331.33K
Shareholders Equity 11.07M 99.99M -12.50M -8.56M
Total Investments n/a n/a n/a n/a